Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06396416 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 29, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Feb 2026 to Sep 30, 2026
    • Study completion pushed from Feb 2026 to Dec 2026
    • Eligibility criteria expanded, about 4 words
    v5
  2. Notable Primary endpoint revisedv4 Show 4 more changesShow less
    • Primary and study completion dates: Dec 2025 to Feb 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: 4 to 16
    • Collaborators revised (3)
  3. Minor Eligibility criteria shortened, about 13 words
    • Site contact updated
    • Collaborators revised (3)
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary completion date: Nov 2025 to Dec 2025
    • Start date changed from estimate of Jun 2024 to Sep 26, 2024
    • Eligibility criteria expanded, about 7 words
    • Site details revised
    • Collaborators revised (3)
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
OK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial. We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight management program or continue their usual care.
Trial Details
NCT Number NCT06396416
Lead Sponsor Western University, Canada
Collaborators: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Queen Elizabeth II Health Sciences Centre, Unity Health Toronto
Conditions
(from sponsor)
Obesity, Chronic Kidney Disease
Related terms Obesity, Renal Insufficiency, Chronic
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov